Introduction
The use of a diet containing a number of cholesterollowering components (dietary portfolio) has been shown to be effective in lowering serum cholesterol (Jenkins et al., 2003a (Jenkins et al., , b, 2005b . The components of the dietary portfolio are all recognized for their cholesterol-lowering effects (United States Food and Drug Administration 2002 , 1999 and current dietary guidelines recommend their incorporation into the diet to reduce coronary heart disease (CHD) risk (Krauss et al., 2000 ; Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, 2001; Grundy et al., 2004b) . The United States Food and Drug Administration has also approved cardiovascular risk reduction health claims for the main cholesterollowering components of the diet (United States Food and Drug Administration 2002 , 1999 .
Less well recognized is the growing body of literature implicating hematologic indices as risk factors for CHD. Interest started in the 1970s in relation to blood viscosity (Dormandy et al., 1973; Dormandy, 1975; Abu-Zeid and Chapman, 1976) as a risk factor for thrombosis. Factors associated with blood viscosity were hemoglobin, hematocrit and fibrinogen, all of which have been shown in separate studies to relate positively to increased CHD risk (Danesh et al., 1998 (Danesh et al., , 2000 Lowe et al., 2000; Woodward et al., 2003) .
In addition, antedating interest in C-reactive protein (CRP) as a marker of inflammation and inflammation itself as a risk factor for CHD, attention had focused on raised white blood cell counts (WBC) and increased CHD risk (Friedman et al., 1974; Danesh et al., 1998; Haim et al., 2004; Horne et al., 2005) . This association of raised WBCs and CRP might now be seen as part of a low-grade pro-inflammatory state (Woodward et al., 2003) . Hematological indices could therefore contribute to CHD risk by increasing both blood viscosity and inflammatory potential.
As we can find no reports of dietary interventions aimed at reducing CHD risk through altering hematological risk factors, we considered it of interest to report the effect of an effective lipid-lowering diet on these measurements. The lipid data were the primary end points of this study and are presented in detail elsewhere (Jenkins et al., 2006) .
Methods
Participants Sixty-six hyperlipidemic participants, 31 men and 35 postmenopausal women, were recruited to start the 1-year study; (mean7s.e.) age 59.371.1 year (range 32-86 years), body mass index (BMI) 27.370.4 kg/m 2 (range 19.1-36.8 kg/m 2 ); the respective values for the 55 completers were: age 59.571.2 year and BMI, 27.370.5 kg/m 2 . Subjects were recruited through two series of newspaper advertisements. Participants' baseline characteristics are shown in Table 1 . The first group of subjects (n ¼ 55) were first recruited for 1 month metabolic trials of portfolio, statin and control diets and 35 individuals (35/55) of this group subsequently went on to start the long-term (1 year) portfolio study (Figure 1) . Subjects for the second recruitment cohort (n ¼ 62) were recruited directly for the long-term portfolio study and this recruitment contributed 31 individuals making a total of 66 ( Figure 1 ). All participants had previously raised low-density lipoprotein-cholesterol (LDL-C) levels (44.1 mmol/l) (Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, 2001) . No participants had a history of cardiovascular disease, diabetes, renal or liver disease. None were taking medications known to influence serum lipids apart from eight women and one man who were on stable doses of thyroxine and had normal TSH levels, and one woman who was taking a stable dose of estrogen replacement therapy. Twenty-three participants had been prescribed cholesterol-lowering medications as part of their usual care but had discontinued them at least 2 weeks before the baseline measurement of the treatment period.
Study protocol
The intervention was a single phase 1-year open label study of a self selected (ad libitum) dietary portfolio of cholesterollowering foods. All subjects had been instructed to follow a diet with less than 7% saturated fat and less than 200 mg/day cholesterol for 2 months before commencing the 1-year study. During the 1-year study, participants were seen at weeks À6, À2, 0, 2, 4, 8, 12, 18, 24, 32, 42 and 52 . At each visit, fasting body weights were checked and blood samples were obtained after 12 h overnight fasts. Bloods for safety measurements including hemoglobin and complete blood count (CBC) were obtained before the start of the study and at weeks 24 and 52. The diet records were discussed with the dietitian and suggestions made to enhance compliance. The previous week's exercise was also recorded and the dietitian 
Diets
Before the study, participants ate their routine therapeutic low-fat diets with mean macronutrient profiles, which were close to current NCEP ATP III guidelines (p7% energy from saturated fat and o200 mg/day dietary cholesterol) (Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, 2001) ( Table 2 ).
The dietary advice for the 1-year study was based on the consumption goals for the same four dietary components, which had been emphasized in previous metabolic dietary portfolio studies (Jenkins et al., 2003a (Jenkins et al., , b, 2005b . Foods were bought by subjects from supermarkets and health food stores with the exception of the bread, which was obtained at cost from the baker (Natural Temptations) and the margarine, which was unobtainable in Canada and provided to all but four subjects. The aim of the dietary portfolio was to provide 1.0 g plant sterols per 1000 kcal of diet in the form of a plant sterol ester enriched margarine; approximately 10 g viscous fibers per 1000 kcal of diet from oats, barley, psyllium and the vegetables, okra and eggplant; 22.5 g soy protein per 1000 kcal as soy milk and soy meat analogues; and 23 g whole almonds per 1000 kcal of diet in addition to their ongoing low-fat diet. To the extent acceptable to participants, advice was given to take a vegetarian diet without the use of dairy foods or eggs. This dietary portfolio has been described in detail previously (Jenkins et al., 2003a (Jenkins et al., b, 2005b .
Self-taring electronic scales (Salter Housewares, Kent, United Kingdom) were provided to all participants. They were asked to weigh all food items consumed in the week before clinic visits and during the study period.
Compliance with the self-selected dietary portfolio was assessed from the completed 7-day food records.
Analyses
CBCs was analyzed on fresh blood samples collected in EDTA tubes (Becton Dickinson, Mississauga, ON) in the routine hospital hematology laboratory of St Michael's Hospital, using a Beckman-Coulter LH 755 analyzer (Beckman Coulter Canada Inc., Mississauga, ON). Complete data on reticulocyte counts were only available on the last 22 subjects. Reticulocytes were visualized by supravital staining with methylene blue (Dacie and Lewis, 1995) , and counted on the Beckman-Coulter LH 755 analyzer.
Red cell fragility was assessed on fresh red cells collected in vacutainer tubes containing EDTA (Becton Dickinson, Mississauga, ON). Packed red cells (0.02 ml) were added to 2 ml unbuffered saline covering the range of sodium chloride concentrations from 3.0 to 5.5 g/l in 0.5 g/l increments. After 1 h, the cells were centrifuged at 1000 g at room temperature for 5 min and the supernatant was read at 540 nm (Fink et al., 1989) . Data are presented as unadjusted optical density (OD) readings and adjusted as a percentage of the maximum OD obtained for both tests combined. The adjusted values were used to calculate the saline concentration that corresponded to the 50% hemolysis value. The p50 value for red cell hemolysis (50% hemolysis value) was calculated, assuming a linear response between the two consecutive OD readings spanning the half point of the maximum hemolysis recorded for the subject. For each subject, the OD obtained with distilled water represented the 100% hemolysis value for that subject. Preliminary data on red cell fragility expressed as 50% hemolysis have been reported previously (Jenkins et al., 2002) .
Seven-day diet records were assessed for macronutrients, fatty acids, cholesterol and fiber using a computer program based on USDA data (The Agricultural Research Service, 1992). Statistical analysis SAS software, version 9.1, was used to conduct all statistical analyses. Results are expressed as means7s.e. The primary analysis was carried out on subjects who completed the study (n ¼ 55). Intent-to-treat analyses were also performed on key hematologic factors with last observations carried forward (LOCF) as well with baseline observations carried forward (BOCF) for those who did not complete the study. All statistical tests were performed at the Po0.05 significance level. Changes in measures from baseline and linear trends over time based on values from weeks 0, 24 and 52 were assessed using generalized linear models (SAS, 2002 (SAS, -2003 .
The repeated measures analysis was performed using the Mixed Model procedure with 'week' in the REPEATED statement and 'subject ID' in the SUBJECT option; a compound symmetry covariance structure was specified. Subjects were also divided into those who fulfilled ATP III criteria for classification of the metabolic syndrome (n ¼ 18) and those who did not (n ¼ 37) (Grundy et al., 2004a) . In determining significance of the difference between these two groups, Satterthwaite t-tests were performed in which no assumption of equal variance was made (Satterthwaite, 1999) .
Linear associations between changes in red cell (hemoglobin, red cell number, hematocrit, platelet volume) and white cell-related measurements (total white cells, polymorphonuclear leukocytes) and compliance measures, as well as between hematological measurements and body weight and blood lipids were tested using Pearson correlation. The complete blood lipid data are presented in detail elsewhere (Jenkins et al., 2006) . Compliance was assessed for the four portfolio components (soy protein, plant sterols, viscous fibers and almonds), where the prescribed amount represented 100%. The total compliance was the sum of the four individual compliances given equal weighting.
Results
Total compliance was adequate at 62.172.7% for completers (n ¼ 55), and this value was similar for the group as a whole (62.672.5%, n ¼ 65). For completers, although total protein remained similar to pre-study values, 18.970.5% of energy versus 20.070.4% at 1 year, animal protein intake as a percent of total calories was reduced from 11.270.6% to 5.670.5%. Over the 1 year of the self-selected dietary portfolio a small but statistically significant weight loss was observed at both 24 and 52 weeks (À0.9570.34 kg, n ¼ 55, P ¼ 0.006, and À0.7070.34 kg, n ¼ 55, P ¼ 0.042, respectively).
Hematologic indices
No subjects had hemoglobin concentrations outside the normal range for men (130-170 g/l) or women (115-155 g/l) at baseline, 6 months or 1 year.
In general, for the completers, hematological values were reduced at 1 year (Table 3) , although not at 6 months, but remained within the normal range. At 1 year, these included hemoglobin (À1.4970.59 g/l, P ¼ 0.013), hematocrit (À0.00770.002 l/l, Po0.001) and red cell number (À0.0770.02 10 9 /l, Po0.001). No change was seen in mean corpuscular volume (MCV). Platelet number was not significantly changed but mean platelet volume was increased (0.1670.07 fl, P ¼ 0.033) suggesting increased platelet turn- (Figure 2) . Furthermore, at 1 year, only one individual had a red cell fragility (5.07 g/l) greater than 2 s.d. above the mean pretreatment value (4.80 g/l) and that individual also had an increased red cell fragility pretreatment (4.88 g/l). The increase in reticulocytes at 1 year was also not significant (5.9174.17 10 9 /l, P ¼ 0.164). In addition to reduced red cell number, there was also a small reduction at 1 year in the total white cell number (À0.3270.14 10 9 /l, P ¼ 0.023), reflected in a reduction in neutrophils (À0.3470.13 10 9 /l, P ¼ 0.014) and a rise in basophils (0.00770.002 10 9 /l, P ¼ 0.003) and a reduction in the neutrophil to lymphocyte ratio (À0.2470.11, P ¼ 0.04) ( Table 4) . In percentage terms, all the statistically significant hematological changes were small although red cell fragility also became significant (Figure 3 ).
Comparisons were made between the significance of baseline, 6-month and 1-year data using three approaches. The completer data set used throughout this paper was compared with data where for dropouts, the LOCF or the BOCF. The completer and BOCF significance levels were almost identical. However, the 1-year repeated measures analysis of the WBC data showed a loss of significance on the LOCF analysis, although the hematological differences remained significant across the treatment period. In addition, despite the differences in significance levels between the LOCF and the completers and BOCF analyses, the means for the LOCF analyses were similar to the respective completer and BOCF analyses.
Metabolic syndrome
The response to the diet did not differ between those with and those without the metabolic syndrome with the exception of the lymphocyte count, which showed an increase in those with the metabolic syndrome of 0.1670.07 10 9 /l compared to a reduction of 0.0670.05 10 9 /l in those without the metabolic syndrome (P ¼ 0.013).
Relation of hematological measurements to compliance
The change over 1 year in hemoglobin, hematocrit, platelets, mean platelet volume, reticulocytes, neutrophils and neutrophil to lymphocyte ratio were compared to the mean total dietary compliance, and compliance with plant sterols, almonds, soy and viscous fiber across the 12-month period in study completers. A significant relation was seen between the plant sterol margarine and reticulocyte count (r ¼ 0.44, n ¼ 22, P ¼ 0.039) and the neutrophil to lymphocyte ratio (r ¼ 0.27, n ¼ 55, P ¼ 0.043). The significance of the reticulocyte association is unclear, as reticulocytes were not significantly increased on the diet. Furthermore, the neutrophil to lymphocyte ratio showed a significant reduction on plant sterols. On the other hand, a positive correlation was seen between plant sterols and both reticulocytes and the neutrophil to lymphocyte ratio. These positive associations may therefore be spurious.
We also assessed change in hemoglobin, with change in neutrophil count, mean platelet volume, reticulocyte count and 50% red cell fragility. No significant associations were seen. Significant associations were seen between change in body weight and red blood cell number (r ¼ 0.31, n ¼ 55, P ¼ 0.023), MCV (r ¼ À0.31, n ¼ 55, P ¼ 0.021) and neutrophil count (r ¼ 0.27, n ¼ 55, P ¼ 0.045); and between change in LDL-C and mean platelet volume (r ¼ À0.28, n ¼ 55, P ¼ 0.036) and lymphocyte count (r ¼ 0.30, n ¼ 55, P ¼ 0.026).
Discussion
We believe that the present study is the first to demonstrate that small but significant mean reductions in hematological risk factors associated with cardiovascular disease can be achieved after application of an effective cholesterollowering diet. Although significant mean reductions were seen in a range of hematological indices in the present study, individual values remained within the normal range with reductions in hemoglobin and hematocrit of 1.070.4% and 1.670.4%, respectively. These changes may be indicators of further potential cardiovascular benefits that a cholesterollowering diet may have in addition to reduced serum lipids.
In the mid-1970s, it was suggested that raised hemoglobin concentrations and hyperviscosity of the blood were risk factors for CHD (Dormandy et al., 1973; Dormandy, 1975; Abu-Zeid and Chapman, 1976) . This effect has been confirmed for hematocrit in a meta-analysis of 16 population-based studies where the relative risk was 1.16 (95% confidence interval (CI) 1.05-1.29) for the comparison of the top versus the bottom third and 1.81 (95% CI 1.19-2.76) for three studies of subjects with pre-existing vascular disease (Danesh et al., 2000) . The estimated mean hematocrit values for the top and bottom thirds were 46.3 and 41.7%, respectively, a relatively small difference within the normal range. As this meta-analysis, further studies have continued to support the hyperviscosity theory for CHD Woodward et al., 2003) .
A link has also been established between inflammation and viscosity with positive associations between the proinflammatory cytokine interleukin (IL)-6 and fibrinogen, white cell count and plasma and blood viscosity (Woodward et al., 1999) . IL-6 in turn stimulates the hepatic production of acute phase proteins of which CRP has attracted much recent attention as a predictor of CHD (Ridker et al., 2000) . CRP has also been shown to relate to hematocrit, WBCs and coagulation factors (Woodward et al., 2003) . In this respect, it is of interest that in shorter term metabolically controlled studies, the dietary portfolio as used in the present study has been shown to reduce CRP (Jenkins et al., 2003b (Jenkins et al., , 2005a . Related to lower hemoglobin, lower serum iron and ferritin concentrations as markers of iron stores have also been suggested to be associated with reduced CHD risk (Sullivan, 1981) in some but not all studies (Sempos et al., 1994; Corti et al., 1997) . Again, a link has been made with CRP, possibly stimulated by the pro-oxidant effect of iron (Williams et al., 2002) . In this respect, it is of interest that blood donation has been associated with a reduced risk of CHD (Meyers et al., 1997; Tuomainen et al., 1997) .
More recently, interest has grown in WBCs and CHD risk. Early studies suggested that the leukocyte count was a predictor of myocardial infarction (Friedman et al., 1974; Ernst et al., 1987) . A meta-analysis using the seven largest studies with 5377 CHD cases concluded that a difference of 2.8 Â 10 9 /l (8.4 versus 5.6 Â 10 9 /l) resulted in a combined risk ratio of 1.4 (95% CI 1.3-1.5; Danesh et al., 1998) . Since then, data from the Bezafibrate Infarction Prevention Study concluded that for every 1000 cells/ìl increase in WBC count, risk for all-cause mortality increased by 6% (Relative Risk 1.06; 95% CI 1.03-1.10) (Haim et al., 2004) . In the present study, the reduction in WBC count would translate into a 2% reduction in CHD based on the above data (Haim et al., 2004) . Recent data suggest that the neutrophil and neutrophil/lymphocyte (N/L) ratio are the best predictors (Horne et al., 2005) . For the N/L ratio, the top versus bottom quartile of 4.71 versus 1.96 increased the hazard ratio 2.2-fold. According to this assessment (Horne et al., 2005) , the reduction in the neutrophil:lymphocyte ratio in the present study would translate into a 10.5% reduction in CHD risk. This reduction is substantial when compared to the reduction in CHD risk ascribed to the lowering of LDL-C concentration by the active ingredients of the dietary portfolio. Under ideal conditions when this diet was Figure 3 Percent difference from baseline at 1-year for hemoglobin, red cell number, hematocrit, platelets and mean platelet volume in the 55 subjects who followed a dietary portfolio (for reticulocytes, n ¼ 22, and for 50% hemolysis, p50, n ¼ 52). *Po0.05.
administered as a metabolically controlled diet, mean 30% reductions were observed in LDL-C (Jenkins et al., 2003a (Jenkins et al., , b, 2005b . If a 1% reduction in LDL-C is assumed to confer a 1% reduction in CHD risk based on the larger statin trials (Scandinavian Simvastatin Survival Study Group, 1994; Downs et al., 1998 ; ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, 2002; Heart Prevention Study Collaborative Group, 2002) , and a 1:2 ratio has been proposed in the past, then the hematological change, if the risk advantage could be added to the LDL-C effect, would represent as much as one quarter of the total CHD risk reduction associated with the diet. The WBC count is also linked to the individuals' inflammatory status and related to circulating CRP (Woodward et al., 2003) . In the present study, WBC, leukocytes and the N/L ratio all showed small but statistically significant reductions.
It is likely to prove difficult to determine the independence of the hematologic risk factors discussed and whether inflammation or blood viscosity are the primary mechanisms by which the cellular elements of the blood influence CHD risk. The cellular elements of the blood all contribute to increasing blood viscosity and thrombus formation along with fibrinogen. Hemoglobin is related to iron status. The increased risk resulting from higher ferritin levels may also act through iron if iron is confirmed as a promoter of oxidative damage leading to CHD (Sullivan, 1981) . The WBCs together with the acute phase protein, CRP, are part of the inflammatory process recently incriminated as a major risk factor for CHD (Ridker et al., 2000) . In this respect, it is of interest that studies have demonstrated a positive association between white cell count and IL-6 (Woodward et al., 1999) , which in turn will stimulate CRP release. Ferritin is also an acute phase protein and will rise and fall with CRP levels. The linkage between these risk factors for CHD is such that they will all tend to change at the same time, thereby increasing uncertainty over which is the prime mover.
WBCs, hematocrit and hemoglobin have all been demonstrated to be related to insulin resistance and compensatory hyperinsulinemia in healthy subjects (Facchini et al., 1992 (Facchini et al., , 1998 Barbieri et al., 2001) . Furthermore, insulin has been shown to increase the neutrophil count (Rassias et al., 2002) . High hematocrit and plasma hemoglobin have been proposed as part of the insulin resistance syndrome with its strong links to CHD (Barbieri et al., 2001) .
There are no clear indications why the diet resulted in the small hematological changes observed. Obese subjects who lose weight and maintain a stable lower weight after a mean weight loss of 32.8 kg following gastric band surgery have been shown to have improved lipid profiles, reduced insulin resistance and lower total white cell and total neutrophil count (Dixon et al., 2004) . In the present study, weight loss was small over 1 year at 0.7 kg. Despite the small weight reduction, change in body weight was significantly related to both red cell and neutrophil number. However, the association with body weight change only accounted for 9.6 and 8.42% of the variation, respectively. Statins have also been proposed to alter white cell function and number. A recent study assessing the effect of 4 and 6 weeks of atorvastatin (20 mg/day) showed no change in white cell count, their distribution or markers of cell activation (Kroger et al., 2003) .
It is possible that subjects became mildly iron deficient, but we did not measure serum iron or ferritin. However, although lower iron stores may account for the minimal change in hemoglobin concentration, the absence of a fall in MCV argues against substantial iron deficiency.
Plant sterols have been suggested to increase red cell fragility or to reduce deformability in studies of spontaneously hypertensive stroke prone rats (Naito et al., 2000; Ratnayake et al., 2000) . The current data demonstrate a significant effect only when the red cell fragility change was compared as a percentage and other human studies have failed to show an increase in red cell fragility or changes in hematological indices with plant sterols (Hendriks et al., 2003; De Jong et al., 2004; Jones et al., 2005) . Small changes in red cell fragility within the physiological range may be part of the explanation for the equally small changes in Hb, although no direct correlation was observed.
It is known that anemia, especially in women, predicts adverse cardiovascular outcomes (Arant et al., 2004) . However, it is important to stress that the changes in hemoglobin seen in the present study were small and within the normal range.
Limitations of the study include a lack of randomized design with no control group, the relatively small sample size, and the lack of CRP measurements to corroborate the WBC measurements. Further studies must therefore be undertaken to address these deficiencies.
We conclude that consumption of a dietary portfolio of cholesterol-lowering ingredients was associated with a modest, but significant 1% reduction in hemoglobin and a reduction in WBC count. These differences are not considered to have any adverse or pathological significance. However, there may be benefits in terms of blood viscosity from small reductions in the cellular elements of the blood as observed in the present study, especially if this change was also an indication of lower protein viscosity through a corresponding reduction in fibrinogen. Furthermore, lower neutrophil count and the reduced neutrophil to lymphocyte ratio, as part of the overall reduction in systemic inflammation, may have additional benefits in terms of minimizing CHD risk. These modest reductions in hematocrit and neutrophils may therefore be indicators of additional improvements in non-lipid risk factors and contribute to reduced CHD risk associated with cholesterol-lowering diets even though an improved blood lipid profile has been the original focus.
